285 related articles for article (PubMed ID: 23869512)
1. Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.
Bakchoul T; Bassler D; Heckmann M; Thiele T; Kiefel V; Gross I; Arnold DM; DiTomasso J; Smith JW; Paes B; Greinacher A
Transfusion; 2014 Mar; 54(3):640-5. PubMed ID: 23869512
[TBL] [Abstract][Full Text] [Related]
2. Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a.
Solh Z; Breakey V; Murthy P; Smith JW; Arnold DM
Transfusion; 2016 May; 56(5):1166-1170. PubMed ID: 26813079
[TBL] [Abstract][Full Text] [Related]
3. Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study.
Honohan A; van't Ende E; Hulzebos C; Lopriore E; van't Verlaat E; Govaert P; Brand A; van der Bom J
Transfusion; 2013 Dec; 53(12):3100-9. PubMed ID: 23441721
[TBL] [Abstract][Full Text] [Related]
4. Management and Neonatal Outcomes of Pregnancies with Fetal/Neonatal Alloimmune Thrombocytopenia: A Single-Center Retrospective Cohort Study.
Ronzoni S; Keunen J; Shah PS; Kelly EN; Windrim R; Seaward PG; Ryan G
Fetal Diagn Ther; 2019; 45(2):85-93. PubMed ID: 29669341
[TBL] [Abstract][Full Text] [Related]
5. Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG.
te Pas AB; Lopriore E; van den Akker ES; Oepkes D; Kanhai HH; Brand A; Walther FJ
Eur J Pediatr; 2007 Oct; 166(10):1057-63. PubMed ID: 17177068
[TBL] [Abstract][Full Text] [Related]
6. Intrauterine use of hyperconcentrated platelet concentrates collected with Trima Accel in a case of neonatal alloimmune thrombocytopenia.
Ringwald J; Schroth M; Faschingbauer F; Strobel J; Strasser E; Schild RL; Goecke TW
Transfusion; 2007 Aug; 47(8):1488-93. PubMed ID: 17655593
[TBL] [Abstract][Full Text] [Related]
7. Severe HPA-15b related neonatal alloimmune thrombocytopenia.
Moncharmont P; Courvoisier S; Pagnier A; Cotta L; Debillon T; Rigal D
Acta Paediatr; 2007 Nov; 96(11):1701-3. PubMed ID: 17850392
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
Wiita AP; Nambiar A
Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
[TBL] [Abstract][Full Text] [Related]
9. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
[TBL] [Abstract][Full Text] [Related]
10. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura.
van der Lugt NM; van Kampen A; Walther FJ; Brand A; Lopriore E
Vox Sang; 2013 Oct; 105(3):236-43. PubMed ID: 23782272
[TBL] [Abstract][Full Text] [Related]
11. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT).
Kiefel V; Bassler D; Kroll H; Paes B; Giers G; Ditomasso J; Alber H; Berns M; Wiebe B; Quenzel EM; Hoch J; Greinacher A
Blood; 2006 May; 107(9):3761-3. PubMed ID: 16403916
[TBL] [Abstract][Full Text] [Related]
12. Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia.
Giers G; Wenzel F; Fischer J; Stockschläder M; Riethmacher R; Lorenz H; Tutschek B
Vox Sang; 2010 Apr; 98(3 Pt 2):423-30. PubMed ID: 19874573
[TBL] [Abstract][Full Text] [Related]
13. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
14. The management of alloimmune neonatal thrombocytopenia.
Blanchette VS; Johnson J; Rand M
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia.
Bassler D; Greinacher A; Okascharoen C; Klenner A; Ditomasso J; Kiefel V; Chan A; Paes B
Transfusion; 2008 Jan; 48(1):92-8. PubMed ID: 17894790
[TBL] [Abstract][Full Text] [Related]
16. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
[TBL] [Abstract][Full Text] [Related]
17. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
[TBL] [Abstract][Full Text] [Related]
18. Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.
Van Der Lugt NM; Kamphuis MM; Paridaans NP; Figee A; Oepkes D; Walther FJ; Lopriore E
Blood Transfus; 2015 Jan; 13(1):66-71. PubMed ID: 24960663
[TBL] [Abstract][Full Text] [Related]
19. A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry.
McQuilten ZK; Wood EM; Savoia H; Cole S
Aust N Z J Obstet Gynaecol; 2011 Jun; 51(3):191-8. PubMed ID: 21631435
[TBL] [Abstract][Full Text] [Related]
20. Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation.
Lucas G; Culliford S; Green F; Sidra G; Calvert A; Green A; Harrison P; Harvey J; Allen D; Smillie D; Masurekar A; Marks D; Russell N; Massey E
Transfusion; 2010 Feb; 50(2):334-9. PubMed ID: 19874563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
